BeOne Medicines Ltd. (BVMF:B1ME34)

BeOne Medicines Statistics

Total Valuation

BeOne Medicines has a market cap or net worth of BRL 186.88 billion. The enterprise value is 177.51 billion.

Market Cap	186.88B
Enterprise Value	177.51B

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.33%
Shares Change (QoQ)	+1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	67.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	106.40
PS Ratio	7.52
PB Ratio	9.10
P/TBV Ratio	9.26
P/FCF Ratio	140.08
P/OCF Ratio	60.04
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-183.39
EV / Sales	7.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	133.06

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.27.

Current Ratio	1.95
Quick Ratio	1.65
Debt / Equity	0.27
Debt / EBITDA	8.77
Debt / FCF	4.19
Interest Coverage	-4.70

Financial Efficiency

Return on equity (ROE) is -4.98% and return on invested capital (ROIC) is -1.37%.

Return on Equity (ROE)	-4.98%
Return on Assets (ROA)	-1.06%
Return on Invested Capital (ROIC)	-1.37%
Return on Capital Employed (ROCE)	-2.48%
Revenue Per Employee	2.26M
Profits Per Employee	-87,994
Employee Count	11,000
Asset Turnover	0.76
Inventory Turnover	1.59

Taxes

In the past 12 months, BeOne Medicines has paid 623.53 million in taxes.

Income Tax	623.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.32% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+63.32%
50-Day Moving Average	60.69
200-Day Moving Average	53.89
Relative Strength Index (RSI)	71.39
Average Volume (20 Days)	41

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.68

Income Statement

In the last 12 months, BeOne Medicines had revenue of BRL 24.86 billion and -967.93 million in losses. Loss per share was -9.06.

Revenue	24.86B
Gross Profit	20.76B
Operating Income	-553.13M
Pretax Income	-344.40M
Net Income	-967.93M
EBITDA	431.28M
EBIT	-553.13M
Loss Per Share	-9.06

Balance Sheet

The company has 15.02 billion in cash and 5.59 billion in debt, giving a net cash position of 9.43 billion.

Cash & Cash Equivalents	15.02B
Total Debt	5.59B
Net Cash	9.43B
Net Cash Per Share	n/a
Equity (Book Value)	20.54B
Book Value Per Share	187.00
Working Capital	11.44B

Cash Flow

In the last 12 months, operating cash flow was 3.11 billion and capital expenditures -1.78 billion, giving a free cash flow of 1.33 billion.

Operating Cash Flow	3.11B
Capital Expenditures	-1.78B
Free Cash Flow	1.33B
FCF Per Share	n/a

Margins

Gross margin is 83.51%, with operating and profit margins of -2.23% and -3.89%.

Gross Margin	83.51%
Operating Margin	-2.23%
Pretax Margin	-1.39%
Profit Margin	-3.89%
EBITDA Margin	1.74%
EBIT Margin	-2.23%
FCF Margin	5.37%

Dividends & Yields

BeOne Medicines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.33%
Shareholder Yield	n/a
Earnings Yield	-0.52%
FCF Yield	0.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BeOne Medicines has an Altman Z-Score of 4.71 and a Piotroski F-Score of 5.

Altman Z-Score	4.71
Piotroski F-Score	5